Politan Capital Management

Founder and Managing Partner Daniel G. Pollick controls investment decisions and portfolio construction. Pollick spent over a decade at Elliott Management before launching Politan in 2017 (per Bloomberg, 2017).

Politan uses fundamental bottom-up research across small to mid-cap markets, screening for companies with operational inefficiencies or capital misallocation. The firm engages management directly via letters and private discussions before filing public 13D positions (per SEC filings).

Politan is structured as an SEC-registered investment adviser and operates as a hedge fund, not a single-family office. The firm is an independent asset manager with a founding team that contributed seed capital (per public record).

Politan operates a pooled investment vehicle (typical hedge fund structure) and accepts capital from institutional investors, family offices, and high-net-worth individuals. The firm does not run separately managed accounts on a disclosed basis.

Politan focuses on publicly traded companies in North America and Europe, typically with enterprise values between $500 million and $10 billion. The firm does not invest in venture-stage or private equity assets (per SEC filings).

Politan does not publicly exclude any sectors, but disclosed positions have concentrated in healthcare (Zymeworks), consumer (Jack in the Box), and food (Papa John's). The firm has not shown activity in financials, energy, or technology sectors.

Politan's seed capital came from the founding partners, including Dan Pollick and John A. Levin (per public record). The firm does not disclose the identity of its limited partners.

Politan runs a smaller, more concentrated portfolio than Elliott (5–10 positions vs Elliott's broad multi-strategy fund), and targets mid-cap companies rather than mega-cap. Pollick also tends to seek board representation through negotiation rather than litigation (per Reuters, 2023).